Article Text

Download PDFPDF
Response to “Comment on ‘Clopidogrel can be an effective complementary prophylactic for drug-refractory migraine with patent foramen ovale’”
  1. Yichen Guo
  1. Department of Neurology, Xi'an Jiaotong University Medical College First Affiliated Hospital, Xi'an, China
  1. Correspondence to Yichen Guo, Department of Neurology, Xi'an Jiaotong University Medical College First Affiliated Hospital, Xi'an 710061, China; 544464092{at}qq.com

Statistics from Altmetric.com

Dear Editor,

We thank Haghdoost and Sacco for their interest and comment1 on our article.2

Our study is a single-center non-randomized open-label trial and each patient was enrolled with a rigorous diagnosis by the neurologist. We ensure that each patient was well represented. The sample size is very small for setting a placebo group, so our study is a self-controlled experiment. However, a meta-analysis3 to quantify the placebo effect of migraine preventive treatment reported that, in the 22 studies they included, they did not find that the percentage of responders with the placebo effect was higher than 35% and the frequency of …

View Full Text

Footnotes

  • Contributors YG: drafting, writing and revising of the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles